European committee: Regulators should deny Merck ' s Lagevrio

A European medical committee says regulators should reject Merck’s COVID-19 treatment Lagevrio for European Union use. The drugmaker said that a European Medicines Agency committee has recommended marketing authorization refusal for the antiviral pill. More than two dozen countries have already…#merck #iv #fda #lagevrio
Source: Reuters: Health - Category: Consumer Health News Source Type: news